Reliably detecting low amounts of high molecular weight impurities during process development and characterization of biopharmaceutical products.
BioPharm International-08-02-2011
The author describes techniques that can be used to provide the analytical data required by ICH Q6B for characterization of monoclonal antibodies.
Overcoming limitations of volumetric techniques and detecting transparent particles.
Advances in Protein Characterization
Advertisement
Advertisement
Trending on BioPharm International
1
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
2
Why Data Quality, Not Regulation, Is the True Barrier to AI in Biologics
3
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
4
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
5
